Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wharton

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
F1000Research|August 7, 2018
Recent advances in pulmonary arterial hypertensionMartin R Wilkins, Jurjan Aman, Lars Harbaum, et al.
Pharmacology & Therapeutics|November 18, 2008
Therapeutic targets in pulmonary arterial hypertensionChristopher J Rhodes, Alexandra Davidson, J Simon R Gibbs, et al.
Heart (British Cardiac Society)|May 12, 2011
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Luke S Howard, et al.
Pharmacology & Therapeutics|May 3, 2016
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the futureMark P Lythgoe, Christopher J Rhodes, Pavandeep Ghataorhe, et al.
Respiratory Research|January 21, 2006
Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cellsEllena J Growcott, Karen G Spink, Xiaohui Ren, et al.
Circulation|November 3, 2010
Proteomic analysis of lung tissues from patients with pulmonary arterial hypertensionVahitha B Abdul-Salam, John Wharton, John Cupitt, et al.
The European Respiratory Journal|February 26, 2021
The pathophysiological role of novel pulmonary arterial hypertension gene <i>SOX17</i>Yukyee Wu, John Wharton, Rachel Walters, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2002
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cellsNeil Davie, Stephen J Haleen, Paul D Upton, et al.
Journal of the American College of Cardiology|July 9, 2011
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insightsChristopher J Rhodes, Luke S Howard, Mark Busbridge, et al.
The Biochemical Journal|June 5, 2014
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxiaLucio Iannone, Lan Zhao, Olivier Dubois, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
F1000Research|August 7, 2018
Recent advances in pulmonary arterial hypertensionMartin R Wilkins, Jurjan Aman, Lars Harbaum, et al.
Pharmacology & Therapeutics|November 18, 2008
Therapeutic targets in pulmonary arterial hypertensionChristopher J Rhodes, Alexandra Davidson, J Simon R Gibbs, et al.
Heart (British Cardiac Society)|May 12, 2011
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Luke S Howard, et al.
Pharmacology & Therapeutics|May 3, 2016
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the futureMark P Lythgoe, Christopher J Rhodes, Pavandeep Ghataorhe, et al.
Respiratory Research|January 21, 2006
Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cellsEllena J Growcott, Karen G Spink, Xiaohui Ren, et al.
Circulation|November 3, 2010
Proteomic analysis of lung tissues from patients with pulmonary arterial hypertensionVahitha B Abdul-Salam, John Wharton, John Cupitt, et al.
The European Respiratory Journal|February 26, 2021
The pathophysiological role of novel pulmonary arterial hypertension gene <i>SOX17</i>Yukyee Wu, John Wharton, Rachel Walters, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2002
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cellsNeil Davie, Stephen J Haleen, Paul D Upton, et al.
Journal of the American College of Cardiology|July 9, 2011
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insightsChristopher J Rhodes, Luke S Howard, Mark Busbridge, et al.
The Biochemical Journal|June 5, 2014
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxiaLucio Iannone, Lan Zhao, Olivier Dubois, et al.
Pageof 7